Modulating the HSP90 control over NFκB/NLRP3/Caspase-1axis is a new therapeutic target in the management of liver fibrosis: Insights into the role ofTAS-116 (Pimitespib)
LifeSciences | 2024
DOI: https://doi.org/10.1016/j.lfs.2024.122966